Hepatitis C is a liver infection spread mainly through blood contact, often with no early symptoms. Awareness of risks such as past injection drug use, unsterile tattoos, transfusions before 1992, or needle exposure supports timely screening, diagnosis by blood tests, curative treatment, and prevention through safer practices. Your complete arc. The GastroDoxs GutDefense Pathway™ is your complete operational framework - a structured patient journey that connects digestive health awareness, education, screening, prevention, diagnosis, and treatment into one seamless board-certified gastroenterologist-commanded arc, guided by expert GI care from your first concern to lasting gut health for life.
Essential facts about hepatitis C infection
Hepatitis C is caused by the hepatitis C virus, which spreads through contact with infected blood. The most common transmission routes include sharing needles or drug equipment, receiving blood transfusions or organ transplants before 1992, needlestick injuries in healthcare settings, and being born to a mother with hepatitis C.
Most people with hepatitis C do not experience symptoms during the early stages of infection. When symptoms do occur, they may include fatigue, fever, nausea, loss of appetite, abdominal discomfort, dark urine, or jaundice. Many people remain asymptomatic for years while the virus causes gradual liver damage.
Screening is recommended for all adults ages 18 and older at least once in their lifetime, anyone born between 1945 and 1965, people who have ever injected drugs, individuals who received blood transfusions before 1992, healthcare workers exposed to infected blood, people with HIV, and anyone with elevated liver enzymes or known liver disease.
The progression from infection to potential complications
Acute hepatitis C refers to the first six months after exposure to the virus. During this phase, some people experience mild symptoms while others have no symptoms at all. Approximately 15 to 25 percent of people clear the virus naturally during the acute phase without treatment. However, the majority develop chronic infection.
When the immune system cannot eliminate the virus within six months, the infection becomes chronic. Chronic hepatitis C means the virus continues to replicate in the liver, causing ongoing inflammation and progressive damage. Without treatment, chronic infection can persist for decades, gradually affecting liver structure and function.
Persistent viral infection triggers continuous immune responses that cause inflammation in liver tissue. Over time, this chronic inflammation leads to fibrosis, the formation of scar tissue in the liver. As fibrosis progresses, it can interfere with blood flow through the liver and impair the organ's ability to perform essential functions.
In some people with untreated chronic hepatitis C, extensive scarring can progress to cirrhosis, a condition where scar tissue replaces healthy liver tissue. Cirrhosis increases the risk of liver failure and liver cancer. The rate of progression varies widely among individuals and depends on factors including age at infection, alcohol use, and other health conditions.
Understanding what different symptom combinations may indicate
| Pattern | Why It Matters | Possible Next Step |
|---|---|---|
| Persistent fatigue with no clear cause, especially in someone with risk factors for hepatitis C | Chronic fatigue is one of the most common symptoms of hepatitis C but is often overlooked because it is nonspecific and can have many causes | Blood test screening for hepatitis C antibodies and liver function tests to evaluate for possible infection |
| Jaundice, dark urine, and light-colored stools appearing together | This combination suggests impaired bile flow and liver dysfunction, which can occur in acute hepatitis or advanced chronic liver disease | Urgent medical evaluation including hepatitis testing, liver function tests, and imaging to assess liver health |
| Abdominal swelling, confusion, and easy bruising in someone with known chronic hepatitis C | These symptoms indicate possible progression to cirrhosis with complications such as ascites, hepatic encephalopathy, and impaired clotting function | Immediate specialist evaluation for advanced liver disease assessment and management of complications |
Understanding transmission routes and risk factors
The most common way hepatitis C spreads is through sharing needles, syringes, or other drug injection equipment. Even a single instance of sharing equipment can transmit the virus. People who currently inject drugs or have ever injected drugs, even once many years ago, are at significant risk and should be screened.
Before widespread screening of the blood supply began in 1992, hepatitis C was transmitted through blood transfusions and organ transplants. Healthcare workers who experience needlestick injuries or other blood exposures are also at risk. People who received clotting factor concentrates before 1987 or underwent long-term hemodialysis have increased risk.
People born between 1945 and 1965 have higher rates of hepatitis C infection and account for most cases in the United States. Other risk factors include having HIV infection, getting tattoos or body piercings with non-sterile equipment, being born to a mother with hepatitis C, and having sexual contact with someone infected with hepatitis C, though sexual transmission is less common.
Hepatitis C spreads through blood-to-blood contact. Understanding how transmission occurs helps identify who should be screened.
Screening tests and diagnostic procedures for hepatitis C detection
The first step in diagnosis is a blood test that checks for hepatitis C antibodies. These antibodies indicate that your immune system has been exposed to the virus at some point. A positive antibody test means you have been infected with hepatitis C, but it does not distinguish between past infection that cleared and current active infection.
If the antibody test is positive, an HCV RNA test is performed to determine if the virus is currently present in your blood. This test detects the genetic material of the virus and confirms active infection. The HCV RNA test also measures viral load, which indicates how much virus is circulating in your bloodstream.
Blood tests measuring liver enzymes and function help assess how well your liver is working and whether inflammation or damage is present. Elevated liver enzymes may indicate active liver inflammation. Additional tests evaluate bilirubin levels, albumin production, and blood clotting factors to assess overall liver function.
To determine the extent of liver scarring, specialists may use non-invasive tests such as FibroScan (transient elastography), which measures liver stiffness, or blood-based fibrosis markers. Imaging studies including ultrasound, CT, or MRI may be performed to visualize the liver structure and check for cirrhosis or other complications. In some cases, liver biopsy may be recommended for detailed tissue analysis.
Early detection through screening allows for timely intervention before serious liver damage occurs.
Our gastroenterology team includes board-certified specialists with advanced training in hepatology and liver disease management. We stay current with the latest advances in hepatitis C screening, diagnosis, and care coordination.
We provide accessible hepatitis C screening, diagnostic testing, and liver health evaluation at our gastroenterology practice. Our team follows evidence-based screening guidelines and uses advanced diagnostic tools to accurately assess infection status and liver function.
Common questions about hepatitis C infection, testing, and care
Board-certified gastroenterologists with hepatology training evaluate and manage patients with hepatitis C-related cirrhosis. Specialists assess liver function, monitor for complications, coordinate care with hepatologists when needed, and provide ongoing management. Advanced cirrhosis may require referral to transplant centers. Our team provides comprehensive evaluation and coordinates appropriate specialist care for complex liver disease.
Both Harvoni and Mavyret are highly effective direct-acting antiviral medications for hepatitis C. The choice depends on your specific viral genotype, liver disease stage, prior treatment history, other medications, and kidney function. Your hepatologist or infectious disease specialist will recommend the most appropriate regimen based on your individual clinical situation. Both medications have excellent cure rates exceeding 95 percent.
FibroScan costs vary based on your insurance coverage, facility fees, and geographic location. Many insurance plans cover FibroScan when medically indicated for hepatitis C evaluation. Our billing team can provide cost estimates and verify your insurance benefits before scheduling. FibroScan is a non-invasive test that measures liver stiffness to assess fibrosis without requiring biopsy.
Hepatitis C antibody screening can often be performed the same day you visit, but results typically take one to three business days. If antibody testing is positive, confirmatory HCV RNA testing is needed, which may take several additional days. Rapid point-of-care antibody tests provide results within 20 minutes but require RNA confirmation. Our team coordinates efficient testing and timely result communication.
Mavyret and Epclusa are both pangenotypic direct-acting antivirals effective against all hepatitis C genotypes. Mavyret is typically taken for eight weeks in treatment-naive patients without cirrhosis, while Epclusa is usually taken for 12 weeks. Both have excellent cure rates. Your specialist selects the regimen based on your genotype, cirrhosis status, prior treatment, kidney function, and drug interactions.
Before starting hepatitis C treatment, several steps are necessary including confirming active infection with HCV RNA testing, determining viral genotype, assessing liver disease stage, checking kidney function, reviewing other medications for interactions, and verifying insurance authorization. This evaluation typically takes one to two weeks. Your specialist will develop an appropriate treatment plan once all necessary information is available.
Hepatitis C treatment during chemotherapy requires careful coordination between your oncologist and hepatologist. Some chemotherapy drugs can interact with hepatitis C medications or affect liver function. Timing of hepatitis C treatment may be adjusted based on your cancer treatment schedule and overall health status. Our team works collaboratively with oncology specialists to determine the safest approach for your specific situation.
Some psoriasis medications, particularly systemic immunosuppressants and biologics, can affect liver function or interact with hepatitis C treatment. Your dermatologist and gastroenterologist should coordinate care to ensure medication safety. Hepatitis C treatment may be prioritized before starting certain psoriasis therapies. Our team reviews all medications and works with your other specialists to develop a safe, coordinated treatment plan.
After liver transplant, patients require regular monitoring for hepatitis C recurrence, liver function, immunosuppression levels, and complications. Monitoring includes periodic blood tests for HCV RNA, liver enzymes, drug levels, kidney function, and imaging studies. Transplant hepatologists coordinate this specialized follow-up care. Our gastroenterology team can provide ongoing digestive health support and coordinate with your transplant center for comprehensive care.
Porphyria is a rare metabolic disorder that can affect medication choices and requires specialized management. Some hepatitis C medications may be used cautiously in certain types of porphyria, but treatment decisions require consultation with specialists experienced in both conditions. Our team can provide initial evaluation and coordinate care with hepatologists and metabolic disease specialists to ensure safe, appropriate treatment planning.
Board-certified gastroenterologists with hepatology expertise manage cirrhosis complications including ascites, hepatic encephalopathy, variceal bleeding, and hepatocellular carcinoma screening. Complex cases may require referral to transplant hepatologists. Our specialists provide comprehensive cirrhosis management, coordinate multidisciplinary care, and refer to advanced centers when transplant evaluation is needed. We ensure continuity of care throughout your treatment journey.
Medication costs vary based on insurance coverage, pharmacy benefits, manufacturer assistance programs, and treatment duration. Both Epclusa and Mavyret have similar list prices, but your out-of-pocket cost depends on your specific insurance plan. Many patients qualify for manufacturer copay assistance or patient assistance programs. Our team works with specialty pharmacies and financial counselors to help you access affordable treatment.
Viral load indicates how much virus is in your blood but does not directly correlate with disease severity or symptoms. Fatigue is common with hepatitis C regardless of viral load. Disease severity is better assessed through liver function tests, fibrosis staging, and clinical evaluation. An 8 million viral load is treatable with modern medications. Your specialist will evaluate liver health comprehensively to determine disease stage and treatment urgency.
Cure is confirmed by an HCV RNA test performed 12 weeks after completing treatment. If the virus is undetectable at this timepoint, you have achieved sustained virologic response, which is considered cure. This test should be done exactly 12 weeks post-treatment for accurate assessment. Your specialist will order this confirmatory test and discuss results. Achieving SVR means the virus is eliminated and liver inflammation will improve.
Yes, reinfection is possible if you are exposed to the virus again after cure. People who continue injection drug use or have ongoing blood exposure risks should be monitored with annual HCV RNA testing. Reinfection can be treated successfully again with antiviral medications. Your gastroenterologist or primary care provider can coordinate ongoing monitoring based on your risk factors and provide counseling on preventing reinfection.
If you have risk factors for hepatitis C or questions about screening, our gastroenterology team is here to help. Early detection through simple blood testing can provide important information about your liver health and guide appropriate next steps.
